Showing results (541-550 of 739) with videos related to

Sort By:
Pageof 74
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Haematologica|May 13, 2008
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trialPatrick B Walter, Eric A Macklin, John Porter, et al.
Transplantation and Cellular Therapy|July 21, 2026
Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD StatusMargery Gang, Megan Othus, Anne-Chloe Olix, et al.
Cancers|March 13, 2024
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 TrialScott R Solomon, Bayard L Powell, Jamie Koprivnikar, et al.
BMC Genomics|January 9, 2016
X. couchianus and X. hellerii genome models provide genomic variation insight among Xiphophorus speciesYingjia Shen, Domitille Chalopin, Tzintzuni Garcia, et al.
Haematologica|July 11, 2020
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibilityMary-Elizabeth M Percival, Megan Othus, Sarah Mirahsani, et al.
Leukemia & Lymphoma|February 25, 2014
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupGeorge S Laszlo, Rhonda E Ries, Chelsea J Gudgeon, et al.
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
Pageof 74